Health Care Costs
A recent study examined the current economic burden attributable to vaccine-preventable diseases among U.S. adults.
There is a lot of talk about biosimilar drugs. What makes a drug a biosimilar?
Researchers found wide variances in the cost of breast cancer chemotherapy, depending on the course of treatment selected.
Patients with cancer incur significant out-of-pocket costs before their Medicare drug benefits activate, and due to those costs, many patients with CML delayed starting their treatment.
Patient abuse of opioids costs the U.S. economy $78.5 billion a year, including the costs of health care, lost productivity, and treatment programs.
Researchers from the University of Miami School of Business Administration and the Florida Atlantic University College of Business present an overview of the impact of the ACA on US health care in its first 5 years.
Ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients result in significant health care charges and extended hospital admissions.
Improvement seen in all age levels, but millions still struggle with the cost of prescription drugs
Younger cancer survivors in Norway were more likely to be financially dependent and unemployed than individuals without cancer.
Number of Medicare beneficiaries getting compounded drugs up 281 percent since 2006
More transparency regarding the costs of various treatment regimens in real time is needed to "choose wisely" for patients, providers, and payers.
Readmission Rates at Hospitals After Cancer-Related Procedures Is Too Complex for Simple Reimbursement RulesJune 17, 2016
Rates of readmission to hospitals after complex cancer surgeries are usually higher in vulnerable hospitals that serve as safety nets in their communities or in hospitals with a large number of Medicaid-insured patients.
What are the practical considerations for implementing a lung cancer screening program in a health care system? This question was addressed by Abbie Begnaud, MD, assistant professor, pulmonary, critical care, University of Minnesota, in a presentation at the 2016 ASCO Annual Meeting.
A month of treatment with the newest cancer drugs, based on those introduced in 2014, was 6 times more expensive at launch than cancer drugs introduced in 2000, after adjusting for inflation.
Access to specialty drugs is significantly reduced when insurers require patients to share the high costs of these drugs. Specialty drugs are often the only chance for patients with cancer to achieve long-term survival.
Offering free pap smears for cervical cancer screening did not increase pap smear frequency in low income women, even though low income and socioeconomic status are more likely to predict women skipping pap smears.
With the January 2016 expiration of the patent on Gleevac, significant cost savings can be realized by insurance companies and patients. Just 15 years ago, Gleevac (imatinib) changed chronic myeloid leukemia (CML) from a fatal disease to a treatable illness.
The Samfund is a not-for-profit organization dedicated to easing the lasting financial effects of cancer treatments for young adults with the disease.
Spending increase due to increased medication use and higher prices, but increase is about half that observed in 2014.
Preexisting Financial Stress Increases Symptom Burden and Lowers Quality of Life for Patients With CancerMarch 16, 2016
Patients with cancer who have limited financial reserves are more likely to have a higher burden of symptoms and a lower quality of life.
Most Patients With Locally Advanced Head and Neck Cancer Use Life-altering Strategies to Cope With Treatment CostsMarch 04, 2016
Cost-coping strategies that alter lifestyle are used by most patients with LAHNC. In addition, perceived social isolation, or lack of social support coupled with increased loneliness, was identified as a risk factor for suboptimal medication adherence and health care utilization during treatment.
Immense financial challenges confront young adults with cancer. As a result of medical bills and the loss of savings, these patients may forgo recommended medications and/or follow-up appointments.
Oncology drug costs continue to rise, and the financial distress patients experience has led many to call for efforts to reduce oncology drug prices. Viable policy interventions will not be free and will involve tradeoffs, according to a team of experts.
Physicians in Pennsylvania call for state- and national-level medical associations to address drug pricing issue.
Intensive care unit survivors have higher mortality, use of hospital resources in five years after discharge.
Palliative care within 2 days of admission lowered costs for patients with cancer and comorbid conditions. In addition, early palliative care reduced direct hospital costs more for patients with a higher number of coexisting conditions.
Economic burden is significantly higher for survivors of colorectal, breast, and prostate cancers compared with persons with no cancer history; however, excess economic burden attributable to cancer varies by cancer site and age.
Affordable Care Act Changes in Medicare Drug Coverage May Not Be Enough to Defray the Costs of Oral Cancer TherapiesDecember 23, 2015
Out-of-pocket costs for Medicare beneficiaries taking oral chemotherapy drugs are high, and despite changes in cost sharing due to the Affordable Care Act, those costs will remain high.
U.S. report shows sharp decrease in families having trouble paying for health care.
A recent study examined the direct and indirect costs for patients with relapsed or refractory multiple myeloma.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|